HIGHLIGHTS
- who: Harsimran Kaur Garcha and collaborators from the Department of Chemical and Physical Sciences, University of Toronto Mississauga, Mississauga Road, Mississauga, ON L L , Canada have published the research: High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of 26/Oct/2022
- what: Given these clinical needs, particularly for the incurable, aggressive, and rare entities of u03b3u03b4 T-NHL and NKTCLs, the authors aimed to design an HDAC6 inhibitor with drug-like properties, explored here via . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.